Home/ Stocks/ IQV

IQVIA Holdings Inc.

IQV XNYS

$178.71 +0.07 (+0.04%) ▲ 15-min delayed

Open

$182.43

High

$182.62

Low

$175.28

Volume

1.08M

Market Cap

$29.83B

About IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Sector: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Employees: 93.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$4.15B	$275.00M	$1.63
FY 2025	$16.31B	$1.36B	$7.91
Q3 2025	$4.10B	$332.00M	$1.94
Q2 2025	$4.02B	$266.00M	$1.55

Related Market News

No specific coverage for IQV yet. Check out our latest market news or earnings calendar.

Get IQV Alerts

Stay ahead with breaking news, price alerts, and expert analysis on IQVIA Holdings Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.